Advertisement
Australia markets closed
  • ALL ORDS

    8,153.70
    +80.10 (+0.99%)
     
  • ASX 200

    7,896.90
    +77.30 (+0.99%)
     
  • AUD/USD

    0.6517
    -0.0019 (-0.29%)
     
  • OIL

    82.37
    +1.02 (+1.25%)
     
  • GOLD

    2,228.90
    +16.20 (+0.73%)
     
  • Bitcoin AUD

    108,799.64
    +1,557.16 (+1.45%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • AUD/EUR

    0.6024
    -0.0006 (-0.10%)
     
  • AUD/NZD

    1.0892
    +0.0012 (+0.11%)
     
  • NZX 50

    12,105.29
    +94.63 (+0.79%)
     
  • NASDAQ

    18,299.71
    +18.86 (+0.10%)
     
  • FTSE

    7,964.93
    +32.95 (+0.42%)
     
  • Dow Jones

    39,789.54
    +29.46 (+0.07%)
     
  • DAX

    18,500.01
    +22.92 (+0.12%)
     
  • Hang Seng

    16,541.42
    +148.58 (+0.91%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     

Tactile Medical to Present at the William Blair 43rd Annual Growth Stock Conference

Tactile Systems Technology, Inc.
Tactile Systems Technology, Inc.

MINNEAPOLIS, May 23, 2023 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will participate in the William Blair 43rd Annual Growth Stock Conference, which is being held at the Loews Chicago Hotel in Chicago, IL from June 6th – 8th. Management will host a presentation with investors on Tuesday, June 6th at 8:00 a.m. Central Time.

A live audio webcast of the presentation will be accessible under the “Events & Webcasts” section of the Company's investor relations website at http://investors.tactilemedical.com. An archive of the webcast will be available for replay following the conference.

About Tactile Systems Technology, Inc. (DBA Tactile Medical)

Tactile Medical is a leader in developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease by helping them live better and care for themselves at home. The company collaborates with clinicians to expand clinical evidence, raise awareness, increase access to care, reduce overall healthcare costs and improve the quality of life for tens of thousands of patients each year.

CONTACT: Investor Inquiries: Mike Piccinino, CFA ICR Westwicke 443-213-0500 investorrelations@tactilemedical.com